X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/beigene-co-founder-and-ex-viela-bio-bd-leader-snag-200m-for-age-related-biotech-with-arch-jumping-in/
https://www.ema.europa.eu/en/documents/overview/uplizna-epar-medicine-overview_en.pdf
https://www.fiercepharma.com/pharma/insider-trading-2-pharma-m-a-deals-made-former-goldman-sachs-compliance-officer-more-than
https://www.biospace.com/article/releases/viela-bio-announces-additional-positive-results-with-uplizna-inebilizumab-cdon-in-patients-with-neuromyelitis-optica-spectrum-disorder-at-the-actrims-2021-forum/
https://www.globenewswire.com/fr/news-release/2021/02/25/2182496/0/en/Viela-Bio-Announces-Additional-Positive-Results-with-UPLIZNA-inebilizumab-cdon-in-Patients-with-Neuromyelitis-Optica-Spectrum-Disorder-at-the-ACTRIMS-2021-Forum.html
https://www.bloomberg.com/news/articles/2021-02-01/horizon-therapeutics-to-purchase-viela-bio-for-3-1-billion
https://www.globenewswire.com/news-release/2020/09/03/2088771/0/en/Viela-Bio-Announces-Data-Presentations-at-the-8th-Joint-ACTRIMS-ECTRIMS-Meeting-MS-Virtual-2020.html
https://www.fiercepharma.com/pharma/astrazeneca-spinoff-viela-bio-scores-first-fda-nod-uplinza
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761142
https://www.globenewswire.com/news-release/2020/06/11/2047190/0/en/Viela-Bio-Announces-U-S-FDA-Approval-of-UPLIZNA-inebilizumab-cdon-for-the-Treatment-of-Neuromyelitis-Optica-Spectrum-Disorder-NMOSD.html
Market Place
Share 
